Others

Cadila Healthcare Ltd. - Notification

| Updated on February 15, 2019 Published on February 15, 2019

Companys purified chick embryo cell rabies vaccine, Vaxirab N, has received the prequalification from the World Health Organisation (WHO).

The group had received the prequalification from the WHO for its purified duck embryo rabies vaccine, Lyssavac N, for purchase by various United Nations Agencies, in 2008. Subsequently, the company migrated to the purified chick embryo cell rabies vaccine, Vaxirab N, which received the WHO prequalification on 7th February 2019.

Pdf Link: Cadila Healthcare Ltd. - Notification

Source : BSE - www.bseindia.com

Published on February 15, 2019
This article is closed for comments.
Please Email the Editor